"Immunotherapy and Vaccination Against Tuberculosis in the AIDS Era."

According to an abstract submitted by the author to the 18th Annual Congress of the European Society of Mycobacteriology, held June 17-18, 1997, in Cordoba, Spain, and to the 2nd International Symposium on Mycobacteria of Clinical Interest, held June 19-20, 1997, in Cordoba, Spain, "Tuberculosis (TB) is considered a re-emerging disease which accounts for more deaths world wide than any other single human pathogen. The HIV epidemic, migration and deficiencies of TB control programmes have contributed mainly to an increased incidence of the disease, particularly within socially deprived groups. Although short course chemotherapy for TB is one of the most cost effective measures available,...

Want to see the full article?

• Purchase this article for only $3.00